Clearmind Medicine CMND 深 滬
等待開盤 05-19 09:30:00 美东时间
0.40
-0.120
-23.08%
華盛通- 最 高0.6031
- 今 開0.5783
- 成交量 6519.40万股
- 最 低 0.3705
- 昨 收 0.52
- 總市值 407.61万
- 52周最高 52.40
- 市盈率 靜 --
- 換手率 639.76%
- 52周最低 0.3705
- 委 比 0.00%
- 總股本 1019.03万
- 歷史最高 7320.00
- 量 比 313.84
- 振 幅 44.73%
- 歷史最低 0.3705
- 每 手 1
- 風險率 18.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Clearmind Medicine Inks Research Agreement With Yissum Research Development To Evaluate Metabolic Efficacy Of MEAI Both In Combination With, Maintenance Therapy Following Tirzepatide Treatment In Diet-Induced Obese Mice
Clearmind Medicine Inc. (Nasdaq: CMND) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second-generation, neuroplastogen-derived
05-18 20:44
Clearmind Medicine Files European Patent Application For Innovative Psychedelic Compounds Targeting The Treatment Of Post-Traumatic Stress Disorder And Other Mental Health Disorders
The European patent application forms part of the Company's exclusive worldwide licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem ("Yissum"). Under the terms of the
05-05 20:52
Clearmind Medicine Evaluates Lead Candidate, CMND-100 (MEAI), For Eligibility For FDA's Breakthrough Therapy Designation
Positive clinical results from Alcohol Use Disorder clinical trial may strengthen potential for eligibility for Breakthrough Therapy DesignationVancouver, Canada, April 27, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine
04-27 19:42
Why Is Clearmind Stock Rising Monday?
Clearmind Medicine shares are trading higher Monday after CMND-100 meets the primary endpoint in its FDA-approved Phase I/IIa clinical trial.
04-20 21:39
Market-Moving News for April 20th
MRVL: 7% | Google Teams Up With Marvell Technology To Build New AI Chips, Invests Heavily In TPU Strategy Amid Nvidia Dominance: Report CMND: 110% | Clearmind Medicine Says CMND-100, Proprietary
04-20 19:30
Why TopBuild Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $17 billion. Shares jump 20.2% to $493.01.
04-20 16:37
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers BNB Plus (NASDAQ:BNBX) stock moved upwards by 12.7% to $0.65 during Tu...
04-15 05:05
Clearmind Medicine Files Patent Application In India Covering Next-Gen Psychedelic-Based Compounds For Treatment Of Mental Health Disorders And Addiction
Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived
03-27 19:33
Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biotech company, has filed a patent application in India for next-generation psychedelic-based compounds targeting mental health disorders and addiction. This submission, part of the company’s expanding global IP portfolio, builds on its collaboration with Yissum Research. The compounds aim to offer safer, more effective treatments compared to traditional psychedelics. The company currently...
03-27 11:32
Clearmind Medicine To Continue Treatment Of Patients In Third Group Of Its Current FDA-Approved Phase I/IIa Clinical Study Of CMND-100 To Treat Alcohol Use Disorder
Clearmind Medicine Inc. (Nasdaq: CMND) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived
03-19 21:42
